New opportunities in the treatment of mixed bacterial infections in women

QR Code

New opportunities in the treatment of mixed bacterial infections in women

Mixed bacterial infections cause reproductive disorders, in the form of inflammatory diseases of the pelvic organs, tubal infertility and ectopic pregnancy. A promising macrolide drug is spiramycin. Spiramycin is a highly effective drug in the treatment of uncomplicated and complicated urinary tract...

Full description

Saved in:

Bibliographic Details
Main Author:	V. N. Kuzmin
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2022-11-01
Series:	Лечащий Врач
Subjects:	bacterial infection pelvic inflammatory disease chlamydia bacterial vaginosis antibiotic therapy
Online Access:	https://journal.lvrach.ru/jour/article/view/992
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rational use of antimicrobials in obstetric practice in view of growing antibiotic resistance
by: A. Z. Khashukoeva, et al.
Published: (2024-06-01)

Communicable Episode 19: ‘Super gonorrhoea’ & other sexually transmitted infections
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

THE ROLE OF BACTERIAL VAGINOSIS IN PRETERM LABOR
by: S. V. Apresyan, et al.
Published: (2016-05-01)

PHARMACOTHERAPEUTIC EFFICACY OF THE PREPARATION «BALIZ-2» IN TREATMENT OF INFLAMMATORY DISEASES
by: T. B. Tsydenova, et al.
Published: (2012-11-01)

Preconception preparation of a married couple, involving the both partners, in frequent occurrences of bacterial vaginosis
by: N. I. Tapilskaya, et al.
Published: (2021-06-01)

MODERN APPROACHES INTEGRATED TREATMENT OF FETOPLACENTAL INSUFFICIENCY IN PREGNANT WOMEN WITH VAGINAL DISBIOSIS
by: F. U. Magaeva, et al.
Published: (2017-10-01)

Bacterial Vaginosis and Trichomononiasis. Fundamental World Guidelines on Management and Therapy of the Patients
by: M. A. Gomberg
Published: (2020-05-01)

CLINICAL AND LABORATORY EFFICIENCY OF TREATMENT OF WOMEN WITH PERIODONTAL DISEASES ON THE BACKGROUND OF BACTERIAL VAGINOSIS
by: A.D. Shulzhenko, et al.
Published: (2018-03-01)

The occurrence and comparative analysis of bacterial vaginosis and its association with urinary tract infections among pregnant women in a tertiary care hospital of Western Uttar Pradesh
by: Khilika Sethi, et al.
Published: (2025-07-01)

Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
by: A. B. Khuraseva, et al.
Published: (2018-11-01)

METRONIDAZOLE EFFICIENCY IN PREPARATIONS FOR CAESAREAN SECTION IN WOMEN WITH BACTERIAL VAGINOSIS
by: A. A. Badaeva, et al.
Published: (2016-09-01)

COMPARATIVE EFFICACY OF BACTERIAL VAGINOSIS LOCAL THERAPY IN PREGNANT WOMEN WITH OBESITY
by: I. O. Makarov, et al.
Published: (2016-09-01)

Microorganisms associated with bacterial vaginosis: diversity and clinical and diagnostic significance
by: N. M. Voropaeva, et al.
Published: (2021-08-01)

Optimization of treatment and prevention of recurrences of bacterial vaginosis in postmenopausal women
by: S.O. Ostafiichuk, et al.
Published: (2024-12-01)

BACTERIAL INFECTIONS IN RECIPIENTS OF RENAL ALLOGRAFT
by: A. V. Vatazin, et al.
Published: (2012-09-01)

The influence of bacterial vaginosis during pregnancy, the fetus and newborn
by: L. V. Maisuradze, et al.
Published: (2014-12-01)

BIOFILM FORMATION AT THE BACTERIAL VAGINOSIS
by: E. S. Berezovskaya, et al.
Published: (2016-05-01)

Bowel obstruction due to Chlamydia trachomatis: a case report and review of literature
by: Yuta Shibasaki, et al.
Published: (2021-02-01)

SPECIFIC DENTAL TREATMENT OF FEMALE PATIENTS WITH BACTERIAL VAGINOSIS
by: А. Shulzhenko, et al.
Published: (2018-03-01)

BACTERIAL (SEPTIC) ARTHRITIS AND PROSTHETIC JOINT INFECTION
by: B. S. Belov, et al.
Published: (2017-04-01)

CLINICAL FEATURES AND MANAGEMENT OF PATIENTS WITH DYSPLASIA OF CERVICAL EPITHELIUM ON THE BACKGROUND OF ABNORMAL MICROBIOCENOSIS OF VAGINA
by: V. V. Schaefer, et al.
Published: (2018-05-01)

Genital microbiota of sexual partners of female patients with bacterial vaginosis is responsible for its recurrences
by: S. V. Barinov, et al.
Published: (2020-09-01)

Overview of the breadth of bacterial resistance development within the framework of antibiotics and antimicrobial peptides
by: Rajendra Kr Roy, et al.
Published: (2025-09-01)

Disrupted Vaginal Microbiota and Increased HPV Infection Risk Among Non-Vaccinated Women: Findings from a Prospective Cohort Study in Kazakhstan
by: Kuralay Kongrtay, et al.
Published: (2025-06-01)

VAGINAL BIOCENOSIS IN PREGNANT WOMEN
by: A. V. Podgornaya, et al.
Published: (2017-12-01)

Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital
by: Khie Chen Lie, et al.
Published: (2022-07-01)

Remote BV Management via Metagenomic Vaginal Microbiome Testing and Telemedicine
by: Krystal Thomas-White, et al.
Published: (2025-07-01)

The Role of Opportunistic Microflora in the Development of Pre-term Delivery and Late Abortions
by: N. A. Tatarova, et al.
Published: (2011-06-01)

Features of immune bacterial vaginosis in pregnant women residing in the zone of ecological trouble
by: L. V. Maisuradze, et al.
Published: (2016-06-01)

Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections
by: Tan Phuoc Ton, et al.
Published: (2025-07-01)

Treatment of patients with chronic bacterial prostatitis
by: V. N. Krupin, et al.
Published: (2019-04-01)

Vaginal microbiome dysbiosis and sexually transmitted infections correlate with concentrations of immunoglobulin isotypes in human cervicovaginal mucus: insights into HIV-1 transmission
by: Matrona M. Akiso, et al.
Published: (2025-07-01)

EVALUATION OF CLINICAL EFFICIENCY OF RESTRICTIVE TACTICS OF ANTIBACTERIAL THERAPY IN CASE OF UNPROVED INFECTION IN NEONATAL INTENSIVE CARE DEPARTMENT
by: G. A. Kudinova, et al.
Published: (2018-01-01)

Bacteriophages as an alternative strategy for the treatment of drug resistant bacterial infections: Current approaches and future perspectives
by: Abayeneh Girma
Published: (2025-12-01)

IL-33 Participates in G. Vaginalis-Induced Bacterial Vaginosis: Involvement of Intravaginal IgA
by: Zhou M, et al.
Published: (2025-06-01)

The Role of MHC Class I and Class II Molecules in Antibacterial Immunity and Treatment of Bacterial Diseases
by: N. V. Petrova, et al.
Published: (2022-11-01)

Etiological profile and risk factors of vulvovaginitis among women of reproductive age in a tertiary care hospital in northern India
by: Agarwal S, et al.
Published: (2025-06-01)

RESPIRATORY PATHOGENS AND ANTI-INFECTIVE IMMUNITY: PECULIARITIES OF THEIR INTERACTION AND OPPORTUNITIES OF THE TREATMENT WITH TOPICAL BACTERIAL LYSATE
by: L. R. Selimzyanova, et al.
Published: (2013-02-01)

Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01)

Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis
by: Nouha Trad, et al.
Published: (2024-12-01)